Disclaimer
The alfapump® system is currently not approved in Canada for commercial use. DSR® therapy is still in development and is currently not approved in the United States or Canada. Any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. Sequana Medical makes no claims of safety or effectiveness of the DSR® therapy in the U.S. or Canada. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.
Report of the Board of Directors
Report of the Statutory Auditor
MARCH 08, 2022
Sequana Medical successfully raises EUR 28.4 million in an equity placement
MARCH 07, 2022
Sequana Medical launches equity placement
Email: IR@sequanamedical.com
Tel: +32 498 053579